We deal with vaccinations. Part 5. Security
We deal with vaccinations. Part 5. Security

Video: We deal with vaccinations. Part 5. Security

Video: We deal with vaccinations. Part 5. Security
Video: Russian Fairy Tale | Ep. 655 2024, May
Anonim

1. The fact that the safety of vaccines is tested without a real placebo, but only in comparison with another vaccine, or in comparison with some toxic substance, we have already found out. But that's not all. There are three other problems with vaccine safety research.

2. Firstly, almost all tests are carried out exclusively on healthy children. That does not prevent manufacturers, the FDA and CDC from recommending vaccinations for not very healthy children, and premature babies, and not only children, and even younger children.

For example, a month ago, the Israeli Ministry of Health began recommending MMR (measles / mumps / rubella) vaccine for infants 6 months and older who travel to Europe, even though there are no studies on the safety of this vaccine for children under one year old.

3. Second, virtually all clinical safety trials seek only short-term effects. They usually last from a few days to several weeks, with rare trials lasting several months. All side effects that occur after this period, by definition, cannot be associated with the vaccine.

4. Third, even when serious side effects occur during the trial, researchers may simply decide that such or other serious side effects, or even death, are not caused by the vaccine, just cross them out and ignore them.

5. Here is an example of a clinical trial for a Daptacel vaccine. To participate in the trial, the child must be absolutely healthy, born after the 37th week, not sensitive to any vaccine component, not have any developmental delays, the family must not have a history of immune diseases, etc.

More or less the same requirements are put forward in all clinical trials of vaccinations.

That is, unlike drugs that are tested on sick people and then given to patients, vaccinations are tested exclusively on perfectly healthy children, and then they are given to healthy and not very healthy, and even very sick.

6. And this is the article that reports the results of the above test:

Safety was tested 30 to 60 days after each dose.

5.2% of children in the test group as well as 5.2% of children in the control group (who received 3 other vaccinations) experienced serious side effects. The researchers decided that all of these serious side effects were completely unrelated to vaccinations. The authors do not report what these side effects were, or on what basis they concluded it.

Some more examples:

7. Clinical trials of the Recombivax-HB vaccine for hepatitis B:

Security was checked for 14 days.

Side effects were reported in 77% of children. Severe side effects were reported in 28 children (1.6%). One child died (SIDS). The authors report that his death is probably unrelated to the vaccine.

8. Clinical trials of the Comvax vaccine against Haemophilus influenzae and hepatitis B:

Security was checked for 14 days.

Serious side effects were reported in 17 infants (1.9%). 3 children died (SIDS). The researchers concluded that all serious side effects, including death, were unrelated to the vaccine.

9. Clinical trials of the vaccine Infanrix hexa:

Security was checked for 30 days.

Severe side effects were reported in 79 infants (2.7%). Almost all of them have nothing to do with vaccination. One child died (SIDS). Of course, it has nothing to do with vaccination.

10. Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria – Tetanus Toxoid – Five-Component Acellular Pertussis (DTaP5), Inactivated Poliovirus (IPV), and Haemophilus influenzae Type b (Hib) Vaccine Compared with a DTaP3-IPV / Hib Vaccine Administered at 3, 5, and 12 Months of Age (Vesikari, 2013, Clin Vaccine Immunol.)

Security was checked for 30 days.

Severe side effects were reported in 8.5% of infants. Almost all of them have nothing to do with vaccination.

eleven. Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants (Marshal, 2015, Pediatrics)

Safety was checked for 6 months.

Serious side effects were reported in 84 infants (5.9%). Two died. No vaccine connection.

12. This is more or less what most safety tests look like. They rarely last more than 6 weeks, they almost always occur, during this short period, serious side effects in a considerable number of absolutely healthy children, which are almost never associated with the vaccine.

In such short clinical trials, it is impossible to identify many autoimmune, cancer, or neurological diseases, as well as many other diseases that are often the result of vaccinations (to be proved later), but which cannot be diagnosed earlier than a few months, or even a few years after vaccination.

Also, the inserts for vaccines usually state that no studies have been conducted on the oncogenicity of the drug, as well as its possible effects on the reproductive system.

Recommended: